This inventor holds 9 USPTO granted patents and 1 published patent application and 10 EPO patents. Top assignees: Sanofi, Sanofi-A Ventis Deutschland Gmbh. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2020
Title: Discovering the Innovations of Inventor Kai Rossen
Introduction
Kai Rossen is a notable inventor based in Frankfurt am Main, Germany. With an impressive portfolio of 9 patents, he has significantly contributed to the field of pharmaceutical innovations. His work revolves around developing new processes that enhance drug production and efficiency.
Latest Patents
Among his latest patents is the "Process for the preparation of fexofenadine and of intermediates used therein." This innovative approach provides a new method for producing fexofenadine, a compound widely utilized in the treatment of allergic symptoms. Another recent patent, "Process for the production of 2-[4-(cyclopropanecarbonyl)phenyl]-2-methyl-propanenitrile," describes a technique for producing an important intermediate compound that can lead to the synthesis of various pharmaceuticals, including Fexofenadine.
Career Highlights
Throughout his career, Kai Rossen has worked with prestigious companies, including Sanofi and Sanofi-Aventis Deutschland GmbH. His expertise in pharmaceutical chemistry has enabled him to develop processes that push the boundaries of conventional methods and improve drug manufacturing.
Collaborations
Rossen has collaborated with remarkable individuals in his field, including Volker Kraft and Hermut Wehlan. These partnerships have fostered an environment of innovation and exploration, resulting in groundbreaking advancements in pharmaceutical processes.
Conclusion
Kai Rossen’s contributions to the field of pharmacy, characterized by his innovative patents and collaborative efforts, underscore his role as a leading inventor. His work not only advances drug production methods but also improves accessibility to effective treatments for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

